Hepatocellular Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy
Conditions: End Stage Liver Disease; Acute Liver Failure; Acute-On-Chronic Liver Failure; Hepatocellular Carcinoma Interventions: Procedure: Donor hepatectomy Sponsors: King Faisal Specialist Hospital& Research Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials

Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)
Conditions: Carcinoma, Hepatocellular; Metabolic Syndrome Interventions: Procedure: Liver resection and simultaneous sleeve gastrectomy for HCC induced by metabolic syndrome; Procedure: Liver resection for HCC induced by metabolic syndrome Sponsors: Ospedale V. Fazzi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma With Portal Vein Tumor Thrombus(PVTT)
Conditions: Stage IIIA Hepatocellular Carcinoma Interventions: Combination Product: Radiotherapy combined with TKI and Anti-PD-1 Antibody Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
Conditions: Cirrhosis ； Tumor Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Project OASIS: Optimizing Approaches to Select Implementation Strategies
Conditions: Cirrhosis; Hepatocellular Carcinoma Interventions: Behavioral: OASIS DA training; Behavioral: Current DA Tool training Sponsors: VA Office of Research and Development; VA Pittsburgh Healthcare System; VA Ann Arbor Healthcare System; VA Palo Alto Health Care System Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
Conditions: Liver Diseases; Hepatocellular Carcinoma; Immunotherapy; Camrelizumab; Lenvatinib Interventions: Procedure: bTAE-HAIC; Drug: Lenvatinib; Drug: Camrelizumab Sponsors: Zhou Qunfang Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Interventions: Drug: Autologous Natural Killer Cell Therapy; Device: Clinimacs Plus Sponsor: Dr Cipto Mangunkusumo General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by Electroporation Ablation
Condition: BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA Intervention: Drug: Durvalumab/Tremelimumab in neoadjuvant and Durvalumab in adjuvant setting Sponsors: Assistance Publique - Hôpitaux de Paris; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials